Practice Change : Use A Screening Tool For Identifying Candidates For Pre Exposure Prophylaxis

1602 Words Feb 25th, 2016 7 Pages
Practice Change: Use of a Screening Tool to Identify Candidates For
Pre-Exposure Prophylaxis
Despite advances in screening and treatment for human immunodeficiency virus (HIV) over the last 30 years, HIV remains a significant global issue (World Health Organization [WHO], 2015; Yagoda & Moore, 2016). The United States (US) experienced a brief decline in new HIV cases, but total HIV incidence has failed to decrease meaningfully in the past 25 years (Yagoda &Moore, 2016). According to the US Department of Health and Human Services (USDHHS) (2015), there are approximately 56,000 new cases of HIV per year and that number has been holding steady over the last decade. Current strategies to prevent HIV transmission include antiretroviral treatment (ART) for HIV-infected people, voluntary medical male circumcisions, HIV testing, harm reduction, and behavioral risk reduction (Baeten & Heffron, 2014).
In 2012, the US Food and Drug Administration (FDA) approved the use of the medication Truvada (emtricitabine/tenofovir disoproxil fumarate) to be used as yet another means to reduce HIV infections (Blumenthal et al., 2015; Plowsker, 2013). The daily use of Truvada for HIV-negative people, in combination with safer sexual practices to prevent the transmission of HIV, is known as Pre-Exposure Prophylaxis (PrEP) (Shaeer, Sherman, Shafiq, & Hardigan, 2014). Studies demonstrate the daily use of PrEP can decrease the incidence of HIV in high-risk groups (Krakower & Mayer,…
Open Document